ТАКТИКА ВЕДЕНИЯ ПАЦИЕНТОВ С ДИФФУЗНЫМ РАКОМ ЖЕЛУДКА, ОБУСЛОВЛЕННЫМ НАСЛЕДСТВЕННЫМИ МУТАЦИЯМИ

Igor Igorevich Bykov, Marina Vyacheslavovna Nemtsova, Tatiana Vitalevna Khorobrykh


Аннотация


В структуре онкологической заболеваемости во всем мире рак желудка занимает пятое место и является третьей среди наиболее распространенных причин смерти от рака, абсолютное число смертельных случаев в год оценивается в 723 000. Подавляющее большинство случаев рака желудка имеют спорадический характер, но известно, что 1–3% являются проявлением наследственных форм и синдромов. Настоящая статья посвящена новым тенденциям и стратегии в управлении риском развития наследственного диффузного рака желудка. Освещены основы генетического консультирования и современные критерии отбора семей, с целью проведения анализа наследственных мутаций. Рассмотрены вопросы эндоскопического скрининга и динамического наблюдения за состоянием слизистой оболочки желудка. Обсужден возможный подход к выбору тактики хирургического лечения в объеме профилактической гатсрэктомии. Обобщены особенности морфологического исследования при наследственно диффузном раке желудка. Изложены принципы послеоперационного ухода. Рассмотрены перспективы медицинского обеспечения пациентов с наследственным диффузным раком желудка.

Ключевые слова


наследственный рак желудка; диффузный рак желудка; мутации гена CDH1; генетическое консультирование

Полный текст:

PDF>PDF

Литература


Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on day/month/year.

Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A.E. E-cadherin germline mutations in familial gastric cancer. Nature, 1998, vol. 392, no. 6674, pp. 402-405.

Fitzgerald R.C., Hardwick R., Huntsman D., Carneiro F., Guilford P., Blair V., Chung D.C., Norton J., Ragunath K., Van Krieken J.H., Dwerryhouse S., Caldas C. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. Journal of Medical Genetics, 2010, vol. 47, no. 7, pp. 436–444.

Hansford S., Kaurah P., Li-Chang H., Woo M., Senz J., Pinheiro H., Schrader K.A., Schaeffer D.F., Shumansky K., Zogopoulos G., Almeida Santos T., Claro I., Carvalho J., Nielsen C., Padilla S., Lum A., Talhouk A., Baker-Lange K., Richardson S., Lewis I., Lindor N.M., Pennell E., MacMillan A., Fernandez B., Keller G., Lynch H., Shah S.P., Guilford P., Gallinger S., Corso G., Roviello F., Caldas C., Oliveria C., Pharoah P.D.P., Huntsman D.G. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncology, 2015, vol. 1, no. 1, pp. 23–32.

Wickremeratne T., Lee C.H., Kirk J., Charlton A., Thomas G., Gaskin K.J. Prophylactic gastrectomy in a 16-year-old. European Journal of Gastroenterology and Hepatology, 2014, vol. 26, no. 3, pp. 353–356.

Pharoah P.D., Guilford P., Caldas C. International Gastric Cancer Linkage C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology, 2001, vol. 121, no. 6, pp. 1348–1353.

Oliveira C., Seruca R., Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. International Journal of Surgical Pathology, 2006, vol. 14, no. 1, pp. 21–33.

Oliveira C., Ferreira P., Nabais S., Campos L., Ferreira A., Cirnes L., Alves C.C., Veiga I., Fragoso M., Regateiro F., Dias L.M., Moreira H., Suriano G., Machado J.C., Lopes C., Castedo S., Carneiro F., Seruca R. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. European Journal of Cancer, 2004, vol. 40, no. 12, pp. 1897–1903.

Benusiglio P.R., Malka D., Rouleau E., De Pauw A., Buecher B., Nogues C., Fourme E., Colas C., Coulet F., Warcoin M., Grandjouan S., Sezeur A., Laurent-Puig P., Moliere D., Tlemsani C., Di Maria M., Byrde V., Delaloge S., Blayau M., Caron O. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicenter study. Journal of Medical Genetics, 2013, vol. 50, no.7, pp. 486–489.

Frebourg T., Oliveira C., Hochain P., Karam R., Manouvrier S., Graziadio C., Vekemans M., Hartmann A., Baert-Desurmont S., Alexandre C., Lejeune Dumoulin S., Marroni C., Martin C., Castedo S., Lovett M., Winston J., Machado J.C., Attie T., Jabs E.W., Cai J., Pellerin P., Triboulet J.P., Scotte M., Le Pessot F., Hedouin A., Carneiro F., Blayau M., Seruca R. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. Journal of Medical Genetics, 2006, vol. 43, no. 2, pp. 138–142.

Van der Post R.S., Vogelaar I.P., Carneiro F., Guilford P., Huntsman D., Hoogerbrugge N., Caldas C., Schreiber K.E., Hardwick R.H., Ausems M.G., Bardram L., Benusiglio P.R., Bisseling T.M., Blair V., Bleiker E., Boussioutas A., Cats A., Coit D., DeGregorio L., Figueiredo J., Ford J.M., Heijkoop E., Hermens R., Humar B., Kaurah P., Keller G., Lai J., Ligtenberg M.J., O’Donovan M., Oliveira C., Pinheiro H., Ragunath K., Rasenberg E., Richardson S., Roviello F., Schackert H., Seruca R., Taylor A., Ter Huurne A., Tischkowitz M., Joe S.T., van Dijck B., van Grieken N.C., van Hillegersberg R., van Sandick J.W., Vehof R., van Krieken J.H., Fitzgerald R.C. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. Journal of Medical Genetics, 2015, vol. 52, no. 6, pp. 361–374.

Barber M., Murrell A., Ito Y., Maia A.T., Hyland .S, Oliveira C., Save V., Carneiro F., Paterson A.L., Grehan N., Dwerryhouse S., Lao-Sirieix P., Caldas C., Fitzgerald R.C. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. Journal of Pathology, 2008, vol. 216, no. 3, pp. 295–306.

Gaston D., Hansford S., Oliveira C., Nightingale M., Pinheiro H., Macgillivray C., Kaurah P., Rideout A.L., Steele P., Soares G., Huang W.Y., Whitehouse S., Blowers S., LeBlanc M.A., Jiang H., Greer W., Samuels M.E., Orr A., Fernandez C.V., Majewski J., Ludman M., Dyack S., Penney L.S., McMaster C.R., Huntsman D., Bedard K. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLOS Genetics, 2014, vol. 10, no. 10.

Lim Y.C., di Pietro M., O’Donovan M., Richardson S., Debiram I., Dwerryhouse S., Hardwick R.H., Tischkowitz M., Caldas C., Ragunath K., Fitzgerald R.C. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Gastrointestinal Endoscopy, 2014, vol. 80, no. 1, pp. 78–87.

Fujita H., Lennerz J.K., Chung D.C., Patel D., Deshpande V., Yoon S.S., Lauwers G.Y. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. American Journal of Surgical Pathology, 2012, vol. 36, no. 11, pp. 1709–1717.

Shaw D., Blair V., Framp A., Harawira P., McLeod M., Guilford P., Parry S., Charlton A., Martin I. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut, 2005, vol. 54, no. 4, pp. 461–468.

Blair V., Martin I., Shaw D., Winship I., Kerr D., Arnold J., Harawira P., McLeod M., Parry S., Charlton A., Findlay M., Cox B., Humar B., More H., Guilford P. Hereditary diffuse gastric cancer: diagnosis and management. Clinical Gastroenterology and Hepatology, 2006, vol. 4, no. 3, pp. 262–275.

Norton J.A., Ham C.M., Van Dam J., Jeffrey R.B., Longacre T.A., Huntsman D.G., Chun N., Kurian A.W., Ford J.M. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Annals of Surgery, 2007, vol. 245 no. 3, pp. 873–879.

Koea J.B., Karpeh M.S., Brennan M.F. Gastric cancer in young patients: demographic, clinicopathological, and prognostic factors in 92 patients. Annals of Surgical Oncology, 2000, vol. 7, no. 5, pp. 346–351.

Stiekema J., Cats A., Kuijpers A., van Coevorden F., Boot H., Jansen E.P., Verheij M., Balague Ponz O., Hauptmann M., van Sandick J.W. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? European Journal of Surgical Oncology, 2013, vol. 39, no.7, pp. 686–693.

Francis W.P., Rodrigues D.M., Perez N.E., Lonardo F., Weaver D., Webber J.D. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer. Journal of the Society of Laparoendscopic Surgeons, 2007, vol. 11, no.1, pp. 142–147.

Choi J., Kim S.G., Im J.P., Kang S.J., Lee H.J., Yang H.K., Kim J.S., Kim W.H., Jung H.C., Song I.S. LymphnodemetastasisinmultiplesynLymph node metastasis in multiple synchronous early gastric cancer. Gastrointestinal Endoscopy, 2011, vol. 74, no.2, pp. 276–284.

Kang H.J., Kim D.H., Jeon T.Y., Lee S.H., Shin N., Chae S.H., Kim G.H., Song G.A., Kim D.H., Srivastava A., Parkdo Y., Lauwers G.Y. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection. Gastrointestinal Endoscopy, 2010, vol. 72, no. 3, pp. 508–515.

Carneiro F., Charlton A., Huntsman D. Hereditary diffuse gastric cancer. In: Bosman F.T., ed. WHO classification of tumours of the digestive system. 4th edn. International Agency for Research on Cancer Scientific Publications, 2010, pp. 59–63.

Bosman F.T., Carneiro F., Hruban R.H., Theise N.D. WHO classification of tumours of the digestive system. 4th edn. International Agency for Research on Cancer Scientific Publications, 2010.

Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta pathologica, microbiologica, et immunologica Scandinavica, 1965, vol. 64, no.1, pp. 31–49.

Pandalai P.K., Lauwers G.Y., Chung D.C., Patel D., Yoon S.S. Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Surgery, 2011, vol. 149, no.3, pp. 347–355.

Bardram L., Hansen T.V., Gerdes A.M., Timshel S., Friis-Hansen L., Federspiel B. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study. Familial Cancer, 2014, vol. 13, no. 2, pp. 231–242.

Carneiro F., Oliveira C., Suriano G., Seruca R. Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. Journal of Clinical Pathology, 2008, vol. 61, no.1: pp. 25–30.

Mills S.E. Histology for pathologists. 3rd edn. Philadelphia, USA: Lippincott Williams & Wilkins, 2007, 1328 p.

Van der Kaaij M.A. et al, unpublished data, 2014.

Van der Post et al, unpublished data, 2014.

Lee A.F., Rees H., Owen D.A., Huntsman D.G. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers. American Journal of Surgical Pathology, 2010, vol. 34, no. 7, pp. 1007–1013.

Oliveira C., Sousa S., Pinheiro H., Karam R., Bordeira-Carrico R., Senz J., Kaurah P., Carvalho J., Pereira R., Gusmao L., Wen X., Cipriano M.A., Yokota J., Carneiro F., Huntsman D., Seruca R. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology, 2009, vol.136, no.7, pp. 2137–2148.

Majewski I.J., Kluijt I., Cats A., Scerri T.S., de Jong D., Kluin R.J., Hansford S., Hogervorst F.B., Bosma A.J., Hofland I., Winter M., Huntsman D., Jonkers J., Bahlo M., Bernards R. An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. Journal of Pathology, 2013, vol. 229, no. 4, pp. 621–629.

Worster E., Liu X., Richardson S., Hardwick R.H., Dwerryhouse S., Caldas C., Fitzgerald R.C. The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study. Annals of Surgery, 2014, vol.260, no. 1, pp. 87–93.

Mine S., Sano T., Tsutsumi K., Murakami Y., Ehara K., Saka M., Hara K., Fukagawa T., Udagawa H., Katai H. Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. Journal of the American College of Surgeons, 2010, vol. 211, no. 5, pp. 628–636.

Paik C.N., Choi M.G., Lim C.H., Park J.M., Chung W.C., Lee K.M., Jun K.H., Song K.Y., Jeon H.M., Chin H.M., Park C.H., Chung I.S. The role of small intestinal bacterial overgrowth in postgastrectomy patients. Neurogastroenterology & Motility, 2011, vol. 23, no. 5, pp. e191–e196.




DOI: https://doi.org/10.12731/wsd-2018-4-88-110

Ссылки

  • На текущий момент ссылки отсутствуют.




(c) 2018 Igor Igorevich Bykov, Marina Vyacheslavovna Nemtsova, Tatiana Vitalevna Khorobrykh

Лицензия Creative Commons
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.

ISSN 2072-0831 (print)

ISSN 2307-9428 (online)

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivs 4.0.

HotLog Яндекс цитирования